Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis C virus seroconversion among young injection drug users: relationships and risks.

Judith A Hahn1, Kimberly Page-Shafer, Paula J Lum

  • 1Department of Epidemiology, University of California, San Francisco, 94110, USA. jhahn@epi.ucsf.edu

The Journal of Infectious Diseases
|November 26, 2002
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring Phosphatidylethanol Cutoffs for Self-Reported Unhealthy Alcohol Use: An International Multi-Site Analysis.

Alcohol, clinical & experimental research·2026
Same author

Gabapentin to achieve HIV viral load suppression in people with risky drinking in Mbarara, Uganda: study protocol for a randomized, double-blinded, placebo-controlled trial (GRAIL).

Trials·2026
Same author

High Prevalence of Unhealthy Alcohol Use Among Persons with HIV, Viral Non-suppression and Any Alcohol Use in Mbarara, Uganda: A Brief Report.

AIDS and behavior·2026
Same author

The Microbiome and Esophageal Disease: Where Are We Now?

Current gastroenterology reports·2026
Same author

Alcohol Consumption and Health Outcomes Among Men in a Rural HIV-Endemic Cohort in South Africa.

Wellcome open research·2026
Same author

Incidence of human papillomavirus infections in women aged 27 years and older in the US: A federated data network study.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026

Young injection drug users (IDUs) face high hepatitis C virus (HCV) infection rates. Key risk factors include sharing needles and drug preparation equipment, often within relationships.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Epidemiology

Background:

  • Hepatitis C virus (HCV) poses a significant public health challenge, particularly among young individuals who inject drugs (IDUs).
  • Understanding the specific transmission dynamics within this population is crucial for effective prevention strategies.

Purpose of the Study:

  • To investigate the primary risk factors contributing to the high incidence of HCV infection among young IDUs.
  • To identify specific behaviors and social dynamics associated with HCV seroconversion in this demographic.

Main Methods:

  • A prospective cohort study was conducted with young IDUs (<30 years old) who initially tested negative for HCV antibodies.
  • Time-dependent regression analyses were employed to examine risk factors for HCV seroconversion.

Related Experiment Videos

Main Results:

  • The study observed an HCV incidence rate of 25.1 per 100 person-years among the 195 participants.
  • Independent risk factors for seroconversion included sharing needles (with partners or non-partners), sharing nonsterile drug preparation equipment, pooling money for drugs, and exchanging sex for money.
  • Forming injecting or sexual partnerships and associated equipment sharing were identified as significant risk factors.

Conclusions:

  • Social relationships and associated high-risk behaviors, such as needle and equipment sharing, are critical drivers of HCV transmission among young IDUs.
  • Interventions must address the relational context of drug use to effectively reduce HCV transmission in this vulnerable group.